Huntington Bancshares Q2 2026: Net Income Jumps 36% to $727M on Cadence Boost, $3B Buyback Authorized
HBAN is trading near its 52-week low of $14.89 (15% above the low).
Summary
Huntington Bancshares posted Q2 2026 net income of $727 million ($0.33/share), up 36% year-over-year, driven by the Cadence acquisition. The board greenlit a $3 billion share buyback, while a $350 million lawsuit looms.
Key Events · Earnings and Guidance · HBAN
-
Q2 Net Income Rises 36% to $727M
Net income attributable to Huntington reached $727 million, or $0.33 per diluted share, compared with $536 million, or $0.34 per share, in Q2 2025. The results include $152 million in acquisition-related expenses.
-
Cadence Acquisition Drives Balance Sheet Growth
Total assets climbed to $284.0 billion, up 26% from year-end 2025, largely due to the February 1, 2026 Cadence acquisition, which added $51.3 billion in assets and $3.5 billion in preliminary goodwill.
-
$3 Billion Share Repurchase Authorized
On April 22, 2026, the board approved a new $3.0 billion share repurchase program. During the first half of 2026, 18.8 million shares were repurchased for $309 million.
-
Credit Quality: NPAs Rise, Reserves Build
Nonperforming assets increased 71% to $1.6 billion, partly from acquired Cadence loans. The allowance for credit losses rose to $3.4 billion (1.78% of total loans), reflecting loan growth and macroeconomic uncertainty.
Analysis · HBAN · Finance
A 36% surge in net income to $727 million highlights Huntington's second quarter, fueled by the February 2026 Cadence acquisition and organic momentum. The balance sheet swelled 26% to $284 billion, with loans climbing 27%. Credit quality remains manageable even as nonperforming assets rose 71% to $1.6 billion, partly reflecting acquired loans. Signaling confidence in its capital position, the board authorized a $3 billion share repurchase program. Meanwhile, a pending lawsuit seeks $350 million in damages, with trial set for November 2026, representing a notable legal risk.
At the time of this filing, HBAN was trading at $17.12 on NASDAQ in the Finance sector, with a market capitalization of approximately $34.7B. The 52-week trading range was $14.89 to $19.46. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.